Financial Analysis: QT Imaging (NASDAQ:QTI) & electroCore (NASDAQ:ECOR)

electroCore (NASDAQ:ECOR) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

Institutional & Insider Ownership

26.7% of electroCore shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 19.7% of electroCore shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current recommendations for electroCore and QT Imaging, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	0	0	1	0	3.00
QT Imaging	0	0	0	0	0.00

Profitability

This table compares electroCore and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
electroCore	-54.40%	-154.45%	-69.16%
QT Imaging	N/A	N/A	-65.94%

Valuation & Earnings

This table compares electroCore and QT Imaging”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$16.03 million	4.64	-$18.83 million	($1.83)	-6.20
QT Imaging	N/A	N/A	-$4.03 million	N/A	N/A

QT Imaging has lower revenue, but higher earnings than electroCore.

Volatility & Risk

electroCore has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.1, suggesting that its share price is 110% less volatile than the S&P 500.

About electroCore

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.